|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Pioglitazone>> Market Analysis Reports |
Market Analysis Reports of Pioglitazone |
|
Pioglitazone base (CAS 111025-46-8) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Pioglitazone hydrochloride (JAN/USP) (CAS 112529-15-4) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). (±)-Pioglitazone-d4 (phenyl-d4) (CAS 1134163-29-3) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Pioglitazone Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Pioglitazone hydrochloride Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). 5-{{4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]-phenyl}-methylene}-2,4-thiazolidinedione (CAS 144809-28-9) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Pioglitazone (CAS 111025-46-8) December 2024 Takeda Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Once-daily dosing with pioglitazone hydrochloride improves insulin sensitivity ... Met, a fixed-dose combination tablet of pioglitazone hydrochloride and metformin, as well ... , a fixed-dose combination tablet of pioglitazone hydrochloride and glimepiride, are ... Global Market Report of 5-Hydroxy Pioglitazone (CAS 625853-74-9) December 2024 Global Market Report of Pioglitazone Impurity (CAS 952188-00-0) December 2024 Global Market Report of 5-Desethyl 5-Carboxy Pioglitazone (CAS 186751-40-6) December 2024 Global Market Report of Pioglitazone (CAS 105355-27-9) December 2024 Global Market Report of Pioglitazone hydrochloride (CAS 112529-15-4) December 2024 Global Market Report of Pioglitazone N-oxide (CAS 145350-09-0) December 2024 Biocon Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Anti-Diabetic Agents (Acarbose, Nateglinide, Pioglitazone, Repaglinide, Rosiglitazone); Anti-Hypertensive Agents ... DepoMed Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... than metformin, such as Takeda's Actos (pioglitazone hydrochloride), GlaxoSmithKline's Avandia (risiglitazon), Pfizer ... Estechpharma Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , Donepezil Hydrochloride for nootropic, and Pioglitazone Hydrochloride for anti-diabetes. The ... Ind-Swift Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... ; Fexofenadine HCL anti histamine; and Pioglitazone HCL, an anti diabetic product. The ... Morepen Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Montelukast, Loratadine, Fexofenadine, Carvedilol, Lamotrigine, Pioglitazone, Fluvastatin, Aliskiren, Quetiapine, Linezolid, Risperidone ... Boya Bio-pharmaceutical Group Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , calcium dobesilate capsules, glimepiride and pioglitazone hydrochloride dispersible tablets, among others ... |